EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 107 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,398,023 | -27.8% | 300,128 | -21.4% | 1.61% | -28.6% |
| Q2 2023 | $3,323,400 | +272.6% | 382,000 | +25.9% | 2.25% | +242.8% |
| Q1 2023 | $891,984 | -16.0% | 303,396 | 0.0% | 0.66% | +0.6% |
| Q4 2022 | $1,061,886 | -55.8% | 303,396 | 0.0% | 0.65% | -36.8% |
| Q3 2022 | $2,400,000 | +0.5% | 303,396 | 0.0% | 1.03% | -22.3% |
| Q2 2022 | $2,388,000 | -36.2% | 303,396 | -1.5% | 1.33% | -23.9% |
| Q1 2022 | $3,742,000 | +25.8% | 307,944 | +26.7% | 1.75% | +39.8% |
| Q4 2021 | $2,975,000 | -22.8% | 243,072 | -34.3% | 1.25% | -8.1% |
| Q3 2021 | $3,854,000 | +15.9% | 369,863 | 0.0% | 1.36% | +2.3% |
| Q2 2021 | $3,325,000 | -14.1% | 369,863 | -3.0% | 1.33% | -4.8% |
| Q1 2021 | $3,872,000 | – | 381,145 | – | 1.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $36,461,013 | 27.59% |
| ACUTA CAPITAL PARTNERS, LLC | 382,000 | $3,323,400 | 2.25% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,423,897 | $29,787,904 | 1.59% |
| Cormorant Asset Management, LP | 3,200,000 | $27,840,000 | 1.56% |
| Caligan Partners LP | 310,298 | $2,699,593 | 1.52% |
| Samsara BioCapital, LLC | 432,000 | $3,758,400 | 0.66% |
| RA Capital Management | 3,370,506 | $29,323,402 | 0.55% |
| SECTORAL ASSET MANAGEMENT INC | 311,277 | $2,708,110 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 209,949 | $1,826,556 | 0.26% |
| BARD ASSOCIATES INC | 30,674 | $266,864 | 0.10% |